nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—ALB—acquired immunodeficiency syndrome	0.135	1	CbGaD
Estradiol—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0345	0.0556	CbGbCtD
Estradiol—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.0178	0.0286	CbGbCtD
Estradiol—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0157	0.0254	CbGbCtD
Estradiol—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0227	CbGbCtD
Estradiol—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.022	CbGbCtD
Estradiol—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0133	0.0214	CbGbCtD
Estradiol—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0129	0.0208	CbGbCtD
Estradiol—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0124	0.02	CbGbCtD
Estradiol—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0199	CbGbCtD
Estradiol—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0199	CbGbCtD
Estradiol—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0121	0.0194	CbGbCtD
Estradiol—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.012	0.0194	CbGbCtD
Estradiol—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0188	CbGbCtD
Estradiol—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0188	CbGbCtD
Estradiol—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0109	0.0176	CbGbCtD
Estradiol—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0103	0.0166	CbGbCtD
Estradiol—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0103	0.0165	CbGbCtD
Estradiol—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.00932	0.015	CbGbCtD
Estradiol—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00928	0.0149	CbGbCtD
Estradiol—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00928	0.0149	CbGbCtD
Estradiol—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00904	0.0146	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00904	0.0146	CbGbCtD
Estradiol—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.00889	0.0143	CbGbCtD
Estradiol—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0081	0.013	CbGbCtD
Estradiol—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0078	0.0126	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0078	0.0126	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00758	0.0122	CbGbCtD
Estradiol—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00758	0.0122	CbGbCtD
Estradiol—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0075	0.0121	CbGbCtD
Estradiol—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00688	0.0111	CbGbCtD
Estradiol—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00685	0.011	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00685	0.011	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00685	0.011	CbGbCtD
Estradiol—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00685	0.011	CbGbCtD
Estradiol—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00678	0.0109	CbGbCtD
Estradiol—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00678	0.0109	CbGbCtD
Estradiol—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00652	0.0105	CbGbCtD
Estradiol—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00652	0.0105	CbGbCtD
Estradiol—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00643	0.0104	CbGbCtD
Estradiol—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00639	0.0103	CbGbCtD
Estradiol—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00613	0.00988	CbGbCtD
Estradiol—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00605	0.00974	CbGbCtD
Estradiol—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00594	0.00956	CbGbCtD
Estradiol—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00585	0.00943	CbGbCtD
Estradiol—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00568	0.00915	CbGbCtD
Estradiol—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.00558	0.00899	CbGbCtD
Estradiol—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.00558	0.00899	CbGbCtD
Estradiol—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00547	0.00881	CbGbCtD
Estradiol—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00547	0.00881	CbGbCtD
Estradiol—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00535	0.00862	CbGbCtD
Estradiol—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00514	0.00828	CbGbCtD
Estradiol—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00514	0.00828	CbGbCtD
Estradiol—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00505	0.00813	CbGbCtD
Estradiol—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00503	0.0081	CbGbCtD
Estradiol—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00503	0.0081	CbGbCtD
Estradiol—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00494	0.00796	CbGbCtD
Estradiol—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00494	0.00796	CbGbCtD
Estradiol—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00488	0.00786	CbGbCtD
Estradiol—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00474	0.00763	CbGbCtD
Estradiol—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00472	0.00761	CbGbCtD
Estradiol—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00458	0.00738	CbGbCtD
Estradiol—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00455	0.00733	CbGbCtD
Estradiol—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00455	0.00733	CbGbCtD
Estradiol—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00441	0.00711	CbGbCtD
Estradiol—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00423	0.00681	CbGbCtD
Estradiol—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00415	0.00668	CbGbCtD
Estradiol—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00415	0.00668	CbGbCtD
Estradiol—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00397	0.0064	CbGbCtD
Estradiol—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00393	0.00632	CbGbCtD
Estradiol—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00383	0.00616	CbGbCtD
Estradiol—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00381	0.00614	CbGbCtD
Estradiol—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00381	0.00614	CbGbCtD
Estradiol—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0037	0.00596	CbGbCtD
Estradiol—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00345	0.00555	CbGbCtD
Estradiol—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00345	0.00555	CbGbCtD
Estradiol—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00335	0.00539	CbGbCtD
Estradiol—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00335	0.00539	CbGbCtD
Estradiol—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0033	0.00532	CbGbCtD
Estradiol—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00321	0.00517	CbGbCtD
Estradiol—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00311	0.00501	CbGbCtD
Estradiol—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00292	0.00471	CbGbCtD
Estradiol—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00292	0.00471	CbGbCtD
Estradiol—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00264	0.00426	CbGbCtD
Estradiol—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00264	0.00426	CbGbCtD
Estradiol—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00248	0.004	CbGbCtD
Estradiol—ESRRB—retina—acquired immunodeficiency syndrome	0.00243	0.043	CbGeAlD
Estradiol—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00228	0.00368	CbGbCtD
Estradiol—SHBG—semen—acquired immunodeficiency syndrome	0.00227	0.0401	CbGeAlD
Estradiol—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00222	0.00357	CbGbCtD
Estradiol—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.002	0.00323	CbGbCtD
Estradiol—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.002	0.00323	CbGbCtD
Estradiol—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00192	0.0031	CbGbCtD
Estradiol—AR—semen—acquired immunodeficiency syndrome	0.00163	0.0288	CbGeAlD
Estradiol—FABP2—digestive system—acquired immunodeficiency syndrome	0.00129	0.0229	CbGeAlD
Estradiol—GPER1—vagina—acquired immunodeficiency syndrome	0.00104	0.0183	CbGeAlD
Estradiol—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0179	CbGeAlD
Estradiol—NR1I2—digestive system—acquired immunodeficiency syndrome	0.000981	0.0173	CbGeAlD
Estradiol—GPER1—nervous system—acquired immunodeficiency syndrome	0.000908	0.016	CbGeAlD
Estradiol—GPER1—central nervous system—acquired immunodeficiency syndrome	0.000874	0.0154	CbGeAlD
Estradiol—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000845	0.0149	CbGeAlD
Estradiol—SHBG—blood plasma—acquired immunodeficiency syndrome	0.000828	0.0146	CbGeAlD
Estradiol—FABP2—lymph node—acquired immunodeficiency syndrome	0.00074	0.0131	CbGeAlD
Estradiol—GPER1—brain—acquired immunodeficiency syndrome	0.000694	0.0123	CbGeAlD
Estradiol—GPER1—lymph node—acquired immunodeficiency syndrome	0.000671	0.0118	CbGeAlD
Estradiol—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000551	0.00972	CbGeAlD
Estradiol—ESRRA—digestive system—acquired immunodeficiency syndrome	0.000546	0.00964	CbGeAlD
Estradiol—SLCO4A1—retina—acquired immunodeficiency syndrome	0.000526	0.00929	CbGeAlD
Estradiol—ESRRA—blood—acquired immunodeficiency syndrome	0.00052	0.00918	CbGeAlD
Estradiol—ESRRA—bone marrow—acquired immunodeficiency syndrome	0.000503	0.00888	CbGeAlD
Estradiol—ESRRA—spinal cord—acquired immunodeficiency syndrome	0.000501	0.00885	CbGeAlD
Estradiol—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.000496	0.00876	CbGeAlD
Estradiol—ESRRA—vagina—acquired immunodeficiency syndrome	0.000482	0.00851	CbGeAlD
Estradiol—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000481	0.00849	CbGeAlD
Estradiol—SLCO1B3—lung—acquired immunodeficiency syndrome	0.000469	0.00829	CbGeAlD
Estradiol—ESRRA—lung—acquired immunodeficiency syndrome	0.000456	0.00805	CbGeAlD
Estradiol—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00045	0.00794	CbGeAlD
Estradiol—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.000448	0.00791	CbGeAlD
Estradiol—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000434	0.00766	CbGeAlD
Estradiol—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000427	0.00754	CbGeAlD
Estradiol—SLCO1C1—spinal cord—acquired immunodeficiency syndrome	0.000423	0.00747	CbGeAlD
Estradiol—ESRRA—nervous system—acquired immunodeficiency syndrome	0.000422	0.00745	CbGeAlD
Estradiol—ESRRA—central nervous system—acquired immunodeficiency syndrome	0.000406	0.00718	CbGeAlD
Estradiol—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000391	0.0069	CbGeAlD
Estradiol—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000389	0.00687	CbGeAlD
Estradiol—UGT1A1—blood—acquired immunodeficiency syndrome	0.000372	0.00657	CbGeAlD
Estradiol—SLCO4A1—digestive system—acquired immunodeficiency syndrome	0.000369	0.00652	CbGeAlD
Estradiol—SLCO1C1—nervous system—acquired immunodeficiency syndrome	0.000357	0.0063	CbGeAlD
Estradiol—SLCO1C1—central nervous system—acquired immunodeficiency syndrome	0.000343	0.00606	CbGeAlD
Estradiol—SLCO4A1—spinal cord—acquired immunodeficiency syndrome	0.000339	0.00599	CbGeAlD
Estradiol—ESR2—lymphoid tissue—acquired immunodeficiency syndrome	0.000332	0.00586	CbGeAlD
Estradiol—ESR2—digestive system—acquired immunodeficiency syndrome	0.000328	0.00578	CbGeAlD
Estradiol—SLCO4A1—vagina—acquired immunodeficiency syndrome	0.000326	0.00576	CbGeAlD
Estradiol—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000326	0.00575	CbGeAlD
Estradiol—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000325	0.00574	CbGeAlD
Estradiol—ESRRA—brain—acquired immunodeficiency syndrome	0.000323	0.0057	CbGeAlD
Estradiol—AOX1—digestive system—acquired immunodeficiency syndrome	0.000315	0.00557	CbGeAlD
Estradiol—ESR2—blood—acquired immunodeficiency syndrome	0.000312	0.00551	CbGeAlD
Estradiol—ESRRA—lymph node—acquired immunodeficiency syndrome	0.000312	0.00551	CbGeAlD
Estradiol—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000311	0.00549	CbGeAlD
Estradiol—SLCO1B1—blood—acquired immunodeficiency syndrome	0.00031	0.00547	CbGeAlD
Estradiol—SLCO4A1—lung—acquired immunodeficiency syndrome	0.000309	0.00545	CbGeAlD
Estradiol—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000307	0.00542	CbGeAlD
Estradiol—SHBG—blood—acquired immunodeficiency syndrome	0.000303	0.00536	CbGeAlD
Estradiol—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000302	0.00533	CbGeAlD
Estradiol—SHBG—bone marrow—acquired immunodeficiency syndrome	0.000294	0.00518	CbGeAlD
Estradiol—ABCC10—blood—acquired immunodeficiency syndrome	0.000292	0.00516	CbGeAlD
Estradiol—ESR2—vagina—acquired immunodeficiency syndrome	0.000289	0.00511	CbGeAlD
Estradiol—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.000288	0.00508	CbGeAlD
Estradiol—AR—skin of body—acquired immunodeficiency syndrome	0.000286	0.00505	CbGeAlD
Estradiol—SLCO4A1—nervous system—acquired immunodeficiency syndrome	0.000286	0.00504	CbGeAlD
Estradiol—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000283	0.005	CbGeAlD
Estradiol—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000282	0.00497	CbGeAlD
Estradiol—SHBG—vagina—acquired immunodeficiency syndrome	0.000281	0.00497	CbGeAlD
Estradiol—AOX1—vagina—acquired immunodeficiency syndrome	0.000279	0.00492	CbGeAlD
Estradiol—SLCO4A1—central nervous system—acquired immunodeficiency syndrome	0.000275	0.00486	CbGeAlD
Estradiol—ESR2—lung—acquired immunodeficiency syndrome	0.000274	0.00483	CbGeAlD
Estradiol—SLCO1C1—brain—acquired immunodeficiency syndrome	0.000273	0.00481	CbGeAlD
Estradiol—ABCC10—vagina—acquired immunodeficiency syndrome	0.000271	0.00479	CbGeAlD
Estradiol—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000265	0.00467	CbGeAlD
Estradiol—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.000264	0.00466	CbGeAlD
Estradiol—AOX1—lung—acquired immunodeficiency syndrome	0.000263	0.00465	CbGeAlD
Estradiol—SLCO1C1—lymph node—acquired immunodeficiency syndrome	0.000263	0.00465	CbGeAlD
Estradiol—SLC22A1—blood—acquired immunodeficiency syndrome	0.000262	0.00462	CbGeAlD
Estradiol—ABCC10—lung—acquired immunodeficiency syndrome	0.000256	0.00453	CbGeAlD
Estradiol—ESR2—nervous system—acquired immunodeficiency syndrome	0.000253	0.00447	CbGeAlD
Estradiol—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000244	0.00431	CbGeAlD
Estradiol—ESR2—central nervous system—acquired immunodeficiency syndrome	0.000244	0.00431	CbGeAlD
Estradiol—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000243	0.00429	CbGeAlD
Estradiol—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000243	0.00428	CbGeAlD
Estradiol—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000241	0.00426	CbGeAlD
Estradiol—SLC22A8—blood—acquired immunodeficiency syndrome	0.000241	0.00425	CbGeAlD
Estradiol—SLCO2B1—lung—acquired immunodeficiency syndrome	0.00024	0.00424	CbGeAlD
Estradiol—SHBG—central nervous system—acquired immunodeficiency syndrome	0.000237	0.00419	CbGeAlD
Estradiol—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000232	0.00409	CbGeAlD
Estradiol—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000231	0.00409	CbGeAlD
Estradiol—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00023	0.00407	CbGeAlD
Estradiol—CYP1B1—blood—acquired immunodeficiency syndrome	0.00023	0.00406	CbGeAlD
Estradiol—AR—digestive system—acquired immunodeficiency syndrome	0.000229	0.00404	CbGeAlD
Estradiol—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000227	0.00401	CbGeAlD
Estradiol—ESR1—digestive system—acquired immunodeficiency syndrome	0.000224	0.00396	CbGeAlD
Estradiol—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.000222	0.00393	CbGeAlD
Estradiol—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000221	0.0039	CbGeAlD
Estradiol—SLC22A3—lung—acquired immunodeficiency syndrome	0.000219	0.00387	CbGeAlD
Estradiol—SLCO4A1—brain—acquired immunodeficiency syndrome	0.000218	0.00386	CbGeAlD
Estradiol—AR—blood—acquired immunodeficiency syndrome	0.000218	0.00384	CbGeAlD
Estradiol—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.000214	0.00378	CbGeAlD
Estradiol—ESR1—blood—acquired immunodeficiency syndrome	0.000214	0.00377	CbGeAlD
Estradiol—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000213	0.00377	CbGeAlD
Estradiol—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000213	0.00375	CbGeAlD
Estradiol—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000212	0.00374	CbGeAlD
Estradiol—SLCO4A1—lymph node—acquired immunodeficiency syndrome	0.000211	0.00373	CbGeAlD
Estradiol—AR—spinal cord—acquired immunodeficiency syndrome	0.00021	0.0037	CbGeAlD
Estradiol—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000205	0.00361	CbGeAlD
Estradiol—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000205	0.00361	CbGeAlD
Estradiol—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000203	0.00359	CbGeAlD
Estradiol—AR—vagina—acquired immunodeficiency syndrome	0.000202	0.00356	CbGeAlD
Estradiol—CYP2C19—blood—acquired immunodeficiency syndrome	0.000202	0.00356	CbGeAlD
Estradiol—CYP1B1—lung—acquired immunodeficiency syndrome	0.000202	0.00356	CbGeAlD
Estradiol—ESR1—vagina—acquired immunodeficiency syndrome	0.000198	0.0035	CbGeAlD
Estradiol—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000197	0.00348	CbGeAlD
Estradiol—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000196	0.00345	CbGeAlD
Estradiol—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000195	0.00345	CbGeAlD
Estradiol—ESR2—brain—acquired immunodeficiency syndrome	0.000194	0.00342	CbGeAlD
Estradiol—AR—lung—acquired immunodeficiency syndrome	0.000191	0.00337	CbGeAlD
Estradiol—SHBG—brain—acquired immunodeficiency syndrome	0.000188	0.00332	CbGeAlD
Estradiol—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000188	0.00332	CbGeAlD
Estradiol—ESR1—lung—acquired immunodeficiency syndrome	0.000187	0.00331	CbGeAlD
Estradiol—ESR2—lymph node—acquired immunodeficiency syndrome	0.000187	0.0033	CbGeAlD
Estradiol—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000187	0.0033	CbGeAlD
Estradiol—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000187	0.0033	CbGeAlD
Estradiol—AOX1—brain—acquired immunodeficiency syndrome	0.000186	0.00329	CbGeAlD
Estradiol—ABCC10—brain—acquired immunodeficiency syndrome	0.000181	0.0032	CbGeAlD
Estradiol—AOX1—lymph node—acquired immunodeficiency syndrome	0.00018	0.00318	CbGeAlD
Estradiol—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.00018	0.00317	CbGeAlD
Estradiol—AR—nervous system—acquired immunodeficiency syndrome	0.000177	0.00312	CbGeAlD
Estradiol—CYP2C8—blood—acquired immunodeficiency syndrome	0.000176	0.00311	CbGeAlD
Estradiol—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000175	0.0031	CbGeAlD
Estradiol—ESR1—nervous system—acquired immunodeficiency syndrome	0.000174	0.00306	CbGeAlD
Estradiol—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000173	0.00305	CbGeAlD
Estradiol—ABCG2—blood—acquired immunodeficiency syndrome	0.000171	0.00302	CbGeAlD
Estradiol—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000171	0.00301	CbGeAlD
Estradiol—AR—central nervous system—acquired immunodeficiency syndrome	0.00017	0.00301	CbGeAlD
Estradiol—SLCO2B1—brain—acquired immunodeficiency syndrome	0.00017	0.003	CbGeAlD
Estradiol—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000167	0.00295	CbGeAlD
Estradiol—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000167	0.00295	CbGeAlD
Estradiol—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000166	0.00293	CbGeAlD
Estradiol—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000165	0.00291	CbGeAlD
Estradiol—CYP1A2—blood—acquired immunodeficiency syndrome	0.000165	0.00291	CbGeAlD
Estradiol—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.000164	0.0029	CbGeAlD
Estradiol—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000164	0.0029	CbGeAlD
Estradiol—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000163	0.00288	CbGeAlD
Estradiol—CYP1A1—blood—acquired immunodeficiency syndrome	0.000163	0.00287	CbGeAlD
Estradiol—SLC22A1—brain—acquired immunodeficiency syndrome	0.000162	0.00287	CbGeAlD
Estradiol—CYP3A5—blood—acquired immunodeficiency syndrome	0.000159	0.00281	CbGeAlD
Estradiol—ABCG2—vagina—acquired immunodeficiency syndrome	0.000159	0.0028	CbGeAlD
Estradiol—CYP2C9—blood—acquired immunodeficiency syndrome	0.000156	0.00276	CbGeAlD
Estradiol—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000156	0.00276	CbGeAlD
Estradiol—ALB—brain—acquired immunodeficiency syndrome	0.000155	0.00275	CbGeAlD
Estradiol—SLC22A3—brain—acquired immunodeficiency syndrome	0.000155	0.00274	CbGeAlD
Estradiol—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000151	0.00266	CbGeAlD
Estradiol—ALB—lymph node—acquired immunodeficiency syndrome	0.00015	0.00265	CbGeAlD
Estradiol—ABCG2—lung—acquired immunodeficiency syndrome	0.00015	0.00265	CbGeAlD
Estradiol—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.00015	0.00265	CbGeAlD
Estradiol—SLC22A8—brain—acquired immunodeficiency syndrome	0.000149	0.00264	CbGeAlD
Estradiol—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000147	0.0026	CbGeAlD
Estradiol—CYP1A2—lung—acquired immunodeficiency syndrome	0.000144	0.00255	CbGeAlD
Estradiol—GPER1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000143	0.00606	CbGpPWpGaD
Estradiol—GPER1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000143	0.00606	CbGpPWpGaD
Estradiol—CYP1B1—brain—acquired immunodeficiency syndrome	0.000143	0.00252	CbGeAlD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000143	0.00605	CbGpPWpGaD
Estradiol—CYP1A1—lung—acquired immunodeficiency syndrome	0.000143	0.00252	CbGeAlD
Estradiol—ESRRA—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000142	0.00603	CbGpPWpGaD
Estradiol—SLCO1B3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000141	0.00597	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000139	0.00592	CbGpPWpGaD
Estradiol—CYP3A5—lung—acquired immunodeficiency syndrome	0.000139	0.00246	CbGeAlD
Estradiol—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000138	0.00243	CbGeAlD
Estradiol—GPER1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000136	0.00577	CbGpPWpGaD
Estradiol—AR—brain—acquired immunodeficiency syndrome	0.000135	0.00239	CbGeAlD
Estradiol—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000135	0.00572	CbGpPWpGaD
Estradiol—ESR1—brain—acquired immunodeficiency syndrome	0.000133	0.00234	CbGeAlD
Estradiol—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000132	0.00233	CbGeAlD
Estradiol—AR—lymph node—acquired immunodeficiency syndrome	0.000131	0.00231	CbGeAlD
Estradiol—ESR1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00013	0.00553	CbGpPWpGaD
Estradiol—NR1I2—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000128	0.00545	CbGpPWpGaD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000128	0.00545	CbGpPWpGaD
Estradiol—ESR1—lymph node—acquired immunodeficiency syndrome	0.000128	0.00226	CbGeAlD
Estradiol—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000127	0.00224	CbGeAlD
Estradiol—ABCB1—retina—acquired immunodeficiency syndrome	0.000126	0.00223	CbGeAlD
Estradiol—GPER1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000126	0.00535	CbGpPWpGaD
Estradiol—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000125	0.00221	CbGeAlD
Estradiol—CYP3A4—blood—acquired immunodeficiency syndrome	0.000119	0.00211	CbGeAlD
Estradiol—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000111	0.00469	CbGpPWpGaD
Estradiol—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.00011	0.00468	CbGpPWpGaD
Estradiol—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.00011	0.00468	CbGpPWpGaD
Estradiol—CYP2C8—brain—acquired immunodeficiency syndrome	0.000109	0.00193	CbGeAlD
Estradiol—GPER1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000109	0.00461	CbGpPWpGaD
Estradiol—ABCG2—brain—acquired immunodeficiency syndrome	0.000106	0.00188	CbGeAlD
Estradiol—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000106	0.00449	CbGpPWpGaD
Estradiol—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000103	0.00181	CbGeAlD
Estradiol—CYP1A1—brain—acquired immunodeficiency syndrome	0.000101	0.00178	CbGeAlD
Estradiol—GPER1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	9.78e-05	0.00415	CbGpPWpGaD
Estradiol—CYP1A1—lymph node—acquired immunodeficiency syndrome	9.75e-05	0.00172	CbGeAlD
Estradiol—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.68e-05	0.00171	CbGeAlD
Estradiol—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	9.46e-05	0.00401	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	9.42e-05	0.004	CbGpPWpGaD
Estradiol—CYP3A4—central nervous system—acquired immunodeficiency syndrome	9.32e-05	0.00165	CbGeAlD
Estradiol—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	9.06e-05	0.00384	CbGpPWpGaD
Estradiol—ESR2—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	9.04e-05	0.00384	CbGpPWpGaD
Estradiol—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.97e-05	0.00158	CbGeAlD
Estradiol—ABCB1—digestive system—acquired immunodeficiency syndrome	8.86e-05	0.00156	CbGeAlD
Estradiol—GPER1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	8.61e-05	0.00366	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	8.58e-05	0.00364	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	8.52e-05	0.00362	CbGpPWpGaD
Estradiol—ABCB1—blood—acquired immunodeficiency syndrome	8.44e-05	0.00149	CbGeAlD
Estradiol—AR—Notch-mediated HES/HEY network—CD4—acquired immunodeficiency syndrome	8.27e-05	0.00351	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.24e-05	0.00349	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.24e-05	0.00349	CbGpPWpGaD
Estradiol—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.17e-05	0.00144	CbGeAlD
Estradiol—ESR1—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	8.16e-05	0.00346	CbGpPWpGaD
Estradiol—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.14e-05	0.00144	CbGeAlD
Estradiol—ESR1—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	8.07e-05	0.00342	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.07e-05	0.00342	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.07e-05	0.00342	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	7.94e-05	0.00337	CbGpPWpGaD
Estradiol—ABCB1—vagina—acquired immunodeficiency syndrome	7.83e-05	0.00138	CbGeAlD
Estradiol—ESRRA—Metabolism—TAT—acquired immunodeficiency syndrome	7.83e-05	0.00332	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	7.79e-05	0.00331	CbGpPWpGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	7.74e-05	0.00328	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.54e-05	0.0032	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.45e-05	0.00316	CbGpPWpGaD
Estradiol—ABCB1—lung—acquired immunodeficiency syndrome	7.4e-05	0.00131	CbGeAlD
Estradiol—GPER1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.32e-05	0.00311	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.32e-05	0.00311	CbGpPWpGaD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	7.26e-05	0.00308	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	7.22e-05	0.00306	CbGpPWpGaD
Estradiol—Estropipate—ALB—acquired immunodeficiency syndrome	7.12e-05	0.5	CrCbGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	6.88e-05	0.00292	CbGpPWpGaD
Estradiol—ABCB1—nervous system—acquired immunodeficiency syndrome	6.85e-05	0.00121	CbGeAlD
Estradiol—ESRRA—Gene Expression—CCNT1—acquired immunodeficiency syndrome	6.84e-05	0.0029	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—AGPS—acquired immunodeficiency syndrome	6.65e-05	0.00282	CbGpPWpGaD
Estradiol—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.6e-05	0.00117	CbGeAlD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	6.41e-05	0.00272	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	6.37e-05	0.0027	CbGpPWpGaD
Estradiol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	6.28e-05	0.000383	CcSEcCtD
Estradiol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	6.27e-05	0.000382	CcSEcCtD
Estradiol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	6.27e-05	0.000382	CcSEcCtD
Estradiol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	6.26e-05	0.000382	CcSEcCtD
Estradiol—Pruritus—Stavudine—acquired immunodeficiency syndrome	6.25e-05	0.000381	CcSEcCtD
Estradiol—Asthenia—Abacavir—acquired immunodeficiency syndrome	6.24e-05	0.000381	CcSEcCtD
Estradiol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	6.24e-05	0.00038	CcSEcCtD
Estradiol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	6.23e-05	0.00038	CcSEcCtD
Estradiol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	6.23e-05	0.00038	CcSEcCtD
Estradiol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	6.23e-05	0.00038	CcSEcCtD
Estradiol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	6.23e-05	0.00038	CcSEcCtD
Estradiol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	6.21e-05	0.000378	CcSEcCtD
Estradiol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	6.2e-05	0.000378	CcSEcCtD
Estradiol—NR1I2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	6.19e-05	0.00263	CbGpPWpGaD
Estradiol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000377	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.18e-05	0.000377	CcSEcCtD
Estradiol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.16e-05	0.000376	CcSEcCtD
Estradiol—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.16e-05	0.000375	CcSEcCtD
Estradiol—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.15e-05	0.000375	CcSEcCtD
Estradiol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.15e-05	0.000375	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000375	CcSEcCtD
Estradiol—Cough—Saquinavir—acquired immunodeficiency syndrome	6.14e-05	0.000375	CcSEcCtD
Estradiol—GPER1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.14e-05	0.0026	CbGpPWpGaD
Estradiol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.000374	CcSEcCtD
Estradiol—Constipation—Indinavir—acquired immunodeficiency syndrome	6.1e-05	0.000372	CcSEcCtD
Estradiol—Pain—Indinavir—acquired immunodeficiency syndrome	6.1e-05	0.000372	CcSEcCtD
Estradiol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.1e-05	0.000372	CcSEcCtD
Estradiol—SLCO4A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	6.1e-05	0.00259	CbGpPWpGaD
Estradiol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.1e-05	0.000372	CcSEcCtD
Estradiol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.09e-05	0.000371	CcSEcCtD
Estradiol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.08e-05	0.000371	CcSEcCtD
Estradiol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.07e-05	0.00037	CcSEcCtD
Estradiol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.07e-05	0.00037	CcSEcCtD
Estradiol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.06e-05	0.00037	CcSEcCtD
Estradiol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.06e-05	0.000369	CcSEcCtD
Estradiol—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000369	CcSEcCtD
Estradiol—GPER1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.04e-05	0.00256	CbGpPWpGaD
Estradiol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.04e-05	0.000369	CcSEcCtD
Estradiol—Nausea—Didanosine—acquired immunodeficiency syndrome	6.04e-05	0.000368	CcSEcCtD
Estradiol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000368	CcSEcCtD
Estradiol—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.02e-05	0.000367	CcSEcCtD
Estradiol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.02e-05	0.000367	CcSEcCtD
Estradiol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.01e-05	0.000367	CcSEcCtD
Estradiol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6e-05	0.000366	CcSEcCtD
Estradiol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000365	CcSEcCtD
Estradiol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000365	CcSEcCtD
Estradiol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000365	CcSEcCtD
Estradiol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	5.97e-05	0.000364	CcSEcCtD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	5.97e-05	0.00253	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	5.97e-05	0.00253	CbGpPWpGaD
Estradiol—Oedema—Ritonavir—acquired immunodeficiency syndrome	5.97e-05	0.000364	CcSEcCtD
Estradiol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	5.95e-05	0.000363	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	5.95e-05	0.000363	CcSEcCtD
Estradiol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	5.94e-05	0.000362	CcSEcCtD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.93e-05	0.00251	CbGpPWpGaD
Estradiol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	5.92e-05	0.000361	CcSEcCtD
Estradiol—AR—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	5.92e-05	0.00251	CbGpPWpGaD
Estradiol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.00036	CcSEcCtD
Estradiol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	5.88e-05	0.000359	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	5.88e-05	0.000359	CcSEcCtD
Estradiol—Shock—Ritonavir—acquired immunodeficiency syndrome	5.87e-05	0.000358	CcSEcCtD
Estradiol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	5.86e-05	0.000358	CcSEcCtD
Estradiol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	5.86e-05	0.000357	CcSEcCtD
Estradiol—Cough—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000357	CcSEcCtD
Estradiol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	5.86e-05	0.000357	CcSEcCtD
Estradiol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	5.85e-05	0.000357	CcSEcCtD
Estradiol—Dizziness—Stavudine—acquired immunodeficiency syndrome	5.84e-05	0.000356	CcSEcCtD
Estradiol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	5.84e-05	0.000356	CcSEcCtD
Estradiol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	5.84e-05	0.000356	CcSEcCtD
Estradiol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000355	CcSEcCtD
Estradiol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	5.82e-05	0.000355	CcSEcCtD
Estradiol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	5.82e-05	0.000355	CcSEcCtD
Estradiol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	5.81e-05	0.000355	CcSEcCtD
Estradiol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	5.8e-05	0.000354	CcSEcCtD
Estradiol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.79e-05	0.000353	CcSEcCtD
Estradiol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	5.79e-05	0.000353	CcSEcCtD
Estradiol—ESR1—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	5.79e-05	0.00246	CbGpPWpGaD
Estradiol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	5.77e-05	0.000352	CcSEcCtD
Estradiol—Pain—Efavirenz—acquired immunodeficiency syndrome	5.77e-05	0.000352	CcSEcCtD
Estradiol—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.77e-05	0.000352	CcSEcCtD
Estradiol—Rash—Nevirapine—acquired immunodeficiency syndrome	5.77e-05	0.000352	CcSEcCtD
Estradiol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	5.76e-05	0.000351	CcSEcCtD
Estradiol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	5.75e-05	0.000351	CcSEcCtD
Estradiol—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.75e-05	0.000351	CcSEcCtD
Estradiol—Oedema—Saquinavir—acquired immunodeficiency syndrome	5.74e-05	0.00035	CcSEcCtD
Estradiol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.74e-05	0.00035	CcSEcCtD
Estradiol—Headache—Nevirapine—acquired immunodeficiency syndrome	5.73e-05	0.000349	CcSEcCtD
Estradiol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.000349	CcSEcCtD
Estradiol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.000349	CcSEcCtD
Estradiol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.000349	CcSEcCtD
Estradiol—Infection—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000348	CcSEcCtD
Estradiol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.000347	CcSEcCtD
Estradiol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	5.68e-05	0.000346	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	5.68e-05	0.000346	CcSEcCtD
Estradiol—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.67e-05	0.000346	CcSEcCtD
Estradiol—Shock—Saquinavir—acquired immunodeficiency syndrome	5.65e-05	0.000345	CcSEcCtD
Estradiol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.65e-05	0.000344	CcSEcCtD
Estradiol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.64e-05	0.000344	CcSEcCtD
Estradiol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.64e-05	0.000344	CcSEcCtD
Estradiol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.63e-05	0.000344	CcSEcCtD
Estradiol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.63e-05	0.000343	CcSEcCtD
Estradiol—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.62e-05	0.000342	CcSEcCtD
Estradiol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.61e-05	0.000342	CcSEcCtD
Estradiol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	5.59e-05	0.000341	CcSEcCtD
Estradiol—Rash—Nelfinavir—acquired immunodeficiency syndrome	5.59e-05	0.000341	CcSEcCtD
Estradiol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	5.58e-05	0.00034	CcSEcCtD
Estradiol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	5.58e-05	0.00034	CcSEcCtD
Estradiol—AR—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	5.58e-05	0.00237	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.57e-05	0.00236	CbGpPWpGaD
Estradiol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.57e-05	0.00034	CcSEcCtD
Estradiol—Rash—Stavudine—acquired immunodeficiency syndrome	5.57e-05	0.00034	CcSEcCtD
Estradiol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.56e-05	0.000339	CcSEcCtD
Estradiol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	5.56e-05	0.000339	CcSEcCtD
Estradiol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.56e-05	0.000339	CcSEcCtD
Estradiol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	5.55e-05	0.000339	CcSEcCtD
Estradiol—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.55e-05	0.000338	CcSEcCtD
Estradiol—Headache—Stavudine—acquired immunodeficiency syndrome	5.53e-05	0.000337	CcSEcCtD
Estradiol—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.53e-05	0.000337	CcSEcCtD
Estradiol—GPER1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.53e-05	0.00235	CbGpPWpGaD
Estradiol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	5.53e-05	0.000337	CcSEcCtD
Estradiol—Constipation—Delavirdine—acquired immunodeficiency syndrome	5.52e-05	0.000337	CcSEcCtD
Estradiol—Pain—Delavirdine—acquired immunodeficiency syndrome	5.52e-05	0.000337	CcSEcCtD
Estradiol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000336	CcSEcCtD
Estradiol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	5.51e-05	0.000336	CcSEcCtD
Estradiol—ESR1—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	5.5e-05	0.00233	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.49e-05	0.00233	CbGpPWpGaD
Estradiol—Rash—Abacavir—acquired immunodeficiency syndrome	5.49e-05	0.000335	CcSEcCtD
Estradiol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.48e-05	0.000334	CcSEcCtD
Estradiol—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.000334	CcSEcCtD
Estradiol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.000334	CcSEcCtD
Estradiol—Headache—Abacavir—acquired immunodeficiency syndrome	5.45e-05	0.000332	CcSEcCtD
Estradiol—Infection—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000332	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.44e-05	0.000332	CcSEcCtD
Estradiol—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.43e-05	0.000331	CcSEcCtD
Estradiol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.43e-05	0.000331	CcSEcCtD
Estradiol—AOX1—Metabolism—TAT—acquired immunodeficiency syndrome	5.42e-05	0.0023	CbGpPWpGaD
Estradiol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.4e-05	0.000329	CcSEcCtD
Estradiol—Shock—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000329	CcSEcCtD
Estradiol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.37e-05	0.000328	CcSEcCtD
Estradiol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.36e-05	0.000327	CcSEcCtD
Estradiol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.36e-05	0.000327	CcSEcCtD
Estradiol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.33e-05	0.000325	CcSEcCtD
Estradiol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.33e-05	0.000325	CcSEcCtD
Estradiol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.32e-05	0.000325	CcSEcCtD
Estradiol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.32e-05	0.000324	CcSEcCtD
Estradiol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.32e-05	0.000324	CcSEcCtD
Estradiol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.31e-05	0.000324	CcSEcCtD
Estradiol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.3e-05	0.000323	CcSEcCtD
Estradiol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.000322	CcSEcCtD
Estradiol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.26e-05	0.000321	CcSEcCtD
Estradiol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.26e-05	0.000321	CcSEcCtD
Estradiol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.25e-05	0.00032	CcSEcCtD
Estradiol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.25e-05	0.00032	CcSEcCtD
Estradiol—Nausea—Stavudine—acquired immunodeficiency syndrome	5.25e-05	0.00032	CcSEcCtD
Estradiol—ABCB1—brain—acquired immunodeficiency syndrome	5.24e-05	0.000925	CbGeAlD
Estradiol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.000319	CcSEcCtD
Estradiol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.2e-05	0.000317	CcSEcCtD
Estradiol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000316	CcSEcCtD
Estradiol—AOX1—Disease—APOBEC3G—acquired immunodeficiency syndrome	5.18e-05	0.0022	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	5.17e-05	0.00219	CbGpPWpGaD
Estradiol—Nausea—Abacavir—acquired immunodeficiency syndrome	5.17e-05	0.000315	CcSEcCtD
Estradiol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.16e-05	0.000315	CcSEcCtD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.16e-05	0.00219	CbGpPWpGaD
Estradiol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.15e-05	0.000314	CcSEcCtD
Estradiol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.15e-05	0.000314	CcSEcCtD
Estradiol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.13e-05	0.000313	CcSEcCtD
Estradiol—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.12e-05	0.000312	CcSEcCtD
Estradiol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.12e-05	0.000312	CcSEcCtD
Estradiol—SLCO1C1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.11e-05	0.00217	CbGpPWpGaD
Estradiol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.11e-05	0.000311	CcSEcCtD
Estradiol—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000311	CcSEcCtD
Estradiol—Pain—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000311	CcSEcCtD
Estradiol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.1e-05	0.000311	CcSEcCtD
Estradiol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.1e-05	0.000311	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.09e-05	0.00216	CbGpPWpGaD
Estradiol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.08e-05	0.00031	CcSEcCtD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.07e-05	0.00215	CbGpPWpGaD
Estradiol—ABCB1—lymph node—acquired immunodeficiency syndrome	5.06e-05	0.000894	CbGeAlD
Estradiol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.06e-05	0.000308	CcSEcCtD
Estradiol—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.05e-05	0.000308	CcSEcCtD
Estradiol—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	5.02e-05	0.00213	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.02e-05	0.00213	CbGpPWpGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.01e-05	0.00213	CbGpPWpGaD
Estradiol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.99e-05	0.000305	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000304	CcSEcCtD
Estradiol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.97e-05	0.000303	CcSEcCtD
Estradiol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.96e-05	0.000302	CcSEcCtD
Estradiol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.96e-05	0.000302	CcSEcCtD
Estradiol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.95e-05	0.000302	CcSEcCtD
Estradiol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.0003	CcSEcCtD
Estradiol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.92e-05	0.0003	CcSEcCtD
Estradiol—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.91e-05	0.0003	CcSEcCtD
Estradiol—Pain—Saquinavir—acquired immunodeficiency syndrome	4.91e-05	0.0003	CcSEcCtD
Estradiol—ESR1—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	4.91e-05	0.00208	CbGpPWpGaD
Estradiol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.89e-05	0.000298	CcSEcCtD
Estradiol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.88e-05	0.000298	CcSEcCtD
Estradiol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.88e-05	0.000298	CcSEcCtD
Estradiol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.88e-05	0.000298	CcSEcCtD
Estradiol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.87e-05	0.000297	CcSEcCtD
Estradiol—Rash—Zidovudine—acquired immunodeficiency syndrome	4.84e-05	0.000295	CcSEcCtD
Estradiol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.84e-05	0.000295	CcSEcCtD
Estradiol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.84e-05	0.000295	CcSEcCtD
Estradiol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000294	CcSEcCtD
Estradiol—Headache—Zidovudine—acquired immunodeficiency syndrome	4.81e-05	0.000293	CcSEcCtD
Estradiol—ESR1—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	4.8e-05	0.00204	CbGpPWpGaD
Estradiol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	4.77e-05	0.000291	CcSEcCtD
Estradiol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.76e-05	0.00029	CcSEcCtD
Estradiol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.75e-05	0.00029	CcSEcCtD
Estradiol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	4.74e-05	0.000289	CcSEcCtD
Estradiol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.73e-05	0.000289	CcSEcCtD
Estradiol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.73e-05	0.000289	CcSEcCtD
Estradiol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.72e-05	0.000288	CcSEcCtD
Estradiol—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.72e-05	0.000288	CcSEcCtD
Estradiol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.72e-05	0.000288	CcSEcCtD
Estradiol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.72e-05	0.000288	CcSEcCtD
Estradiol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000286	CcSEcCtD
Estradiol—Pain—Lamivudine—acquired immunodeficiency syndrome	4.69e-05	0.000286	CcSEcCtD
Estradiol—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.69e-05	0.000286	CcSEcCtD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.67e-05	0.00198	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	4.67e-05	0.00198	CbGpPWpGaD
Estradiol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.63e-05	0.000282	CcSEcCtD
Estradiol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.61e-05	0.000281	CcSEcCtD
Estradiol—AOX1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.61e-05	0.00196	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.6e-05	0.00195	CbGpPWpGaD
Estradiol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.57e-05	0.000278	CcSEcCtD
Estradiol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.56e-05	0.000278	CcSEcCtD
Estradiol—ESR1—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	4.56e-05	0.00193	CbGpPWpGaD
Estradiol—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.56e-05	0.000278	CcSEcCtD
Estradiol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.54e-05	0.000277	CcSEcCtD
Estradiol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.54e-05	0.000277	CcSEcCtD
Estradiol—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.54e-05	0.000277	CcSEcCtD
Estradiol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.52e-05	0.000275	CcSEcCtD
Estradiol—Rash—Indinavir—acquired immunodeficiency syndrome	4.5e-05	0.000274	CcSEcCtD
Estradiol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.5e-05	0.000274	CcSEcCtD
Estradiol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.000273	CcSEcCtD
Estradiol—Headache—Indinavir—acquired immunodeficiency syndrome	4.47e-05	0.000273	CcSEcCtD
Estradiol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.46e-05	0.000272	CcSEcCtD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	4.45e-05	0.00189	CbGpPWpGaD
Estradiol—Estrone—ALB—acquired immunodeficiency syndrome	4.43e-05	0.311	CrCbGaD
Estradiol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.42e-05	0.000269	CcSEcCtD
Estradiol—AOX1—Disease—CCNT1—acquired immunodeficiency syndrome	4.4e-05	0.00187	CbGpPWpGaD
Estradiol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.4e-05	0.000268	CcSEcCtD
Estradiol—ESR1—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	4.36e-05	0.00185	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	4.35e-05	0.00185	CbGpPWpGaD
Estradiol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.35e-05	0.000265	CcSEcCtD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	4.34e-05	0.00184	CbGpPWpGaD
Estradiol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.33e-05	0.000264	CcSEcCtD
Estradiol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.33e-05	0.000264	CcSEcCtD
Estradiol—GPER1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.33e-05	0.00184	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.33e-05	0.00184	CbGpPWpGaD
Estradiol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.29e-05	0.000262	CcSEcCtD
Estradiol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.28e-05	0.000261	CcSEcCtD
Estradiol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.27e-05	0.00026	CcSEcCtD
Estradiol—ESR1—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	4.26e-05	0.00181	CbGpPWpGaD
Estradiol—Rash—Efavirenz—acquired immunodeficiency syndrome	4.25e-05	0.000259	CcSEcCtD
Estradiol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.25e-05	0.000259	CcSEcCtD
Estradiol—Nausea—Indinavir—acquired immunodeficiency syndrome	4.24e-05	0.000259	CcSEcCtD
Estradiol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.23e-05	0.000258	CcSEcCtD
Estradiol—Headache—Efavirenz—acquired immunodeficiency syndrome	4.23e-05	0.000258	CcSEcCtD
Estradiol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.22e-05	0.000257	CcSEcCtD
Estradiol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.12e-05	0.000251	CcSEcCtD
Estradiol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.1e-05	0.00025	CcSEcCtD
Estradiol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.08e-05	0.000249	CcSEcCtD
Estradiol—Rash—Delavirdine—acquired immunodeficiency syndrome	4.07e-05	0.000248	CcSEcCtD
Estradiol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.07e-05	0.000248	CcSEcCtD
Estradiol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.06e-05	0.000248	CcSEcCtD
Estradiol—Headache—Delavirdine—acquired immunodeficiency syndrome	4.04e-05	0.000247	CcSEcCtD
Estradiol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.04e-05	0.000246	CcSEcCtD
Estradiol—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.01e-05	0.000244	CcSEcCtD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	3.95e-05	0.00168	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—TAT—acquired immunodeficiency syndrome	3.95e-05	0.00168	CbGpPWpGaD
Estradiol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.95e-05	0.000241	CcSEcCtD
Estradiol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.00024	CcSEcCtD
Estradiol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.93e-05	0.00024	CcSEcCtD
Estradiol—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	3.92e-05	0.00166	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	3.92e-05	0.00166	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	3.88e-05	0.00165	CbGpPWpGaD
Estradiol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.88e-05	0.000236	CcSEcCtD
Estradiol—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.83e-05	0.000234	CcSEcCtD
Estradiol—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	3.81e-05	0.00162	CbGpPWpGaD
Estradiol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.8e-05	0.000232	CcSEcCtD
Estradiol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.000231	CcSEcCtD
Estradiol—Rash—Ritonavir—acquired immunodeficiency syndrome	3.76e-05	0.000229	CcSEcCtD
Estradiol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.76e-05	0.000229	CcSEcCtD
Estradiol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.75e-05	0.000229	CcSEcCtD
Estradiol—Headache—Ritonavir—acquired immunodeficiency syndrome	3.74e-05	0.000228	CcSEcCtD
Estradiol—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	3.73e-05	0.00158	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	3.73e-05	0.00158	CbGpPWpGaD
Estradiol—SLCO2B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.71e-05	0.00157	CbGpPWpGaD
Estradiol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.65e-05	0.000223	CcSEcCtD
Estradiol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.62e-05	0.000221	CcSEcCtD
Estradiol—Rash—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.000221	CcSEcCtD
Estradiol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.62e-05	0.000221	CcSEcCtD
Estradiol—Headache—Saquinavir—acquired immunodeficiency syndrome	3.6e-05	0.000219	CcSEcCtD
Estradiol—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.54e-05	0.000216	CcSEcCtD
Estradiol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.000212	CcSEcCtD
Estradiol—Rash—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000211	CcSEcCtD
Estradiol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000211	CcSEcCtD
Estradiol—Headache—Lamivudine—acquired immunodeficiency syndrome	3.43e-05	0.000209	CcSEcCtD
Estradiol—ABCC10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.43e-05	0.00145	CbGpPWpGaD
Estradiol—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.41e-05	0.000208	CcSEcCtD
Estradiol—SLCO1B3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.36e-05	0.00143	CbGpPWpGaD
Estradiol—SLC22A11—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.36e-05	0.00142	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.3e-05	0.0014	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.29e-05	0.0014	CbGpPWpGaD
Estradiol—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000198	CcSEcCtD
Estradiol—ESR2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.24e-05	0.00138	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.24e-05	0.00138	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.19e-05	0.00136	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.18e-05	0.00135	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.1e-05	0.00132	CbGpPWpGaD
Estradiol—SLCO4A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.1e-05	0.00131	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.06e-05	0.0013	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	3.04e-05	0.00129	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.97e-05	0.00126	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.91e-05	0.00124	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.9e-05	0.00123	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.9e-05	0.00123	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.9e-05	0.00123	CbGpPWpGaD
Estradiol—SLCO1B3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.89e-05	0.00123	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	2.88e-05	0.00122	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	2.88e-05	0.00122	CbGpPWpGaD
Estradiol—ESR1—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	2.87e-05	0.00122	CbGpPWpGaD
Estradiol—AR—Gene Expression—CCNT1—acquired immunodeficiency syndrome	2.85e-05	0.00121	CbGpPWpGaD
Estradiol—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.84e-05	0.00121	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.83e-05	0.0012	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.76e-05	0.00117	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	2.7e-05	0.00115	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	2.7e-05	0.00114	CbGpPWpGaD
Estradiol—Testosterone—ALB—acquired immunodeficiency syndrome	2.7e-05	0.189	CrCbGaD
Estradiol—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	2.65e-05	0.00113	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.64e-05	0.00112	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.62e-05	0.00111	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.6e-05	0.0011	CbGpPWpGaD
Estradiol—SLCO1C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.6e-05	0.0011	CbGpPWpGaD
Estradiol—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.56e-05	0.00109	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	2.52e-05	0.00107	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	2.51e-05	0.00106	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.46e-05	0.00104	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	2.46e-05	0.00104	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	2.44e-05	0.00103	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.43e-05	0.00103	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	2.42e-05	0.00102	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	2.41e-05	0.00102	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.37e-05	0.00101	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.36e-05	0.001	CbGpPWpGaD
Estradiol—AOX1—Disease—CXCR4—acquired immunodeficiency syndrome	2.31e-05	0.000981	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	2.3e-05	0.000978	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.3e-05	0.000975	CbGpPWpGaD
Estradiol—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.27e-05	0.000965	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.27e-05	0.000962	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.26e-05	0.000958	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—CCNT1—acquired immunodeficiency syndrome	2.2e-05	0.000931	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.12e-05	0.000901	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.09e-05	0.000887	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	2.07e-05	0.000879	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.07e-05	0.000877	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.05e-05	0.000869	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	2.03e-05	0.000859	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	1.97e-05	0.000834	CbGpPWpGaD
Estradiol—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	1.95e-05	0.000827	CbGpPWpGaD
Estradiol—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.94e-05	0.000825	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	1.94e-05	0.000824	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.93e-05	0.000818	CbGpPWpGaD
Estradiol—SLCO2B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.88e-05	0.000799	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.83e-05	0.000778	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.83e-05	0.000778	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.81e-05	0.000766	CbGpPWpGaD
Estradiol—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.78e-05	0.000756	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.76e-05	0.000747	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.71e-05	0.000727	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.71e-05	0.000727	CbGpPWpGaD
Estradiol—SLC22A11—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.71e-05	0.000724	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.7e-05	0.000723	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	1.66e-05	0.000706	CbGpPWpGaD
Estradiol—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.66e-05	0.000705	CbGpPWpGaD
Estradiol—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	1.59e-05	0.000673	CbGpPWpGaD
Estradiol—AOX1—Disease—CCR5—acquired immunodeficiency syndrome	1.59e-05	0.000673	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.56e-05	0.000662	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.55e-05	0.000656	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	1.53e-05	0.000647	CbGpPWpGaD
Estradiol—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	1.52e-05	0.000643	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	1.5e-05	0.000635	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.49e-05	0.000633	CbGpPWpGaD
Estradiol—SLCO1B3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.47e-05	0.000624	CbGpPWpGaD
Estradiol—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.44e-05	0.000613	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.43e-05	0.000606	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.43e-05	0.000606	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.41e-05	0.0006	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.39e-05	0.00059	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-05	0.000579	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	1.36e-05	0.000578	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	1.35e-05	0.000572	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.33e-05	0.000564	CbGpPWpGaD
Estradiol—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000552	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	1.3e-05	0.00055	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.29e-05	0.000548	CbGpPWpGaD
Estradiol—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.29e-05	0.000547	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.28e-05	0.000543	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.26e-05	0.000535	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.24e-05	0.000527	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.22e-05	0.000516	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.16e-05	0.000491	CbGpPWpGaD
Estradiol—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.16e-05	0.00049	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.13e-05	0.000479	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.06e-05	0.00045	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000449	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.06e-05	0.000448	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.04e-05	0.000441	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000435	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.01e-05	0.000427	CbGpPWpGaD
Estradiol—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1e-05	0.000425	CbGpPWpGaD
Estradiol—AOX1—Disease—CD4—acquired immunodeficiency syndrome	9.95e-06	0.000422	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.88e-06	0.000419	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ALB—acquired immunodeficiency syndrome	9.46e-06	0.000401	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.15e-06	0.000388	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.05e-06	0.000384	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	9.02e-06	0.000383	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.82e-06	0.000374	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.44e-06	0.000358	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	8.19e-06	0.000347	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.97e-06	0.000338	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.5e-06	0.000318	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.5e-06	0.000318	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	7.36e-06	0.000312	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	6.96e-06	0.000295	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ALB—acquired immunodeficiency syndrome	6.89e-06	0.000292	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	6.76e-06	0.000287	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.51e-06	0.000276	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.97e-06	0.000253	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.7e-06	0.000242	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.62e-06	0.000238	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.41e-06	0.00023	CbGpPWpGaD
Estradiol—AOX1—Disease—IL6—acquired immunodeficiency syndrome	5.38e-06	0.000228	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.33e-06	0.000226	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	5.29e-06	0.000224	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.14e-06	0.000218	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.05e-06	0.000214	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.95e-06	0.00021	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.86e-06	0.000206	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	4.71e-06	0.0002	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	4.63e-06	0.000196	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	4.29e-06	0.000182	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	4.25e-06	0.00018	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.24e-06	0.00018	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.15e-06	0.000176	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.95e-06	0.000168	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	3.07e-06	0.00013	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.97e-06	0.000126	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	2.9e-06	0.000123	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	2.66e-06	0.000113	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	2.37e-06	0.000101	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.32e-06	9.83e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.16e-06	9.18e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.85e-06	7.85e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.75e-06	7.41e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.43e-06	6.06e-05	CbGpPWpGaD
